Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?

Introduction: Drug-induced liver injury (DILI) represents a serious medical challenge and a potentially fatal adverse event. Currently, DILI is a diagnosis of exclusion, and whilst the electronic evaluation of serious drug-induced hepatotoxicity (eDISH) have revolutionised the early assessment of DI...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Expert opinion on drug safety Ročník 15; číslo 5; s. 625 - 634
Hlavní autori:	Clarke, Joanna I., Dear, James W., Antoine, Daniel J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Taylor & Francis 03.05.2016
Predmet:	Acetaminophen Acetaminophen - adverse effects Biomarkers - metabolism Chemical and Drug Induced Liver Injury - diagnosis Chemical and Drug Induced Liver Injury - etiology Chemical and Drug Induced Liver Injury - therapy DILI Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - physiopathology Humans idiosyncratic Prognosis qualification Sensitivity and Specificity qualification DILI Acetaminophen idiosyncratic
ISSN:	1474-0338, 1744-764X, 1744-764X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!